The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this clinical trial publication.

The aim of this study was to investigate the relationship between elevated macroprolactin content and vitamin D status.

Why It Was Studied

Macroprolactinemia is a frequent cause of misdiagnosis and mismanagement of patients with elevated prolactin levels.

Who Took Part

The study group was 20 women.

The age groups tagged for this paper are adults, women only.

How the Study Was Run

The design is described as pilot.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

What Was Measured

Macroprolactinemia is a frequent cause of misdiagnosis and mismanagement of patients with elevated prolactin levels.

The subject headings attached to it are Hyperprolactinemia, Pilot Projects, Prolactin and Vitamin D.

What This Means in Plain Language

The paper is a pilot study of Vitamin D, K2, Magnesium and Zinc in 20 women.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2015 (Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.